CIFRAN

This brand name is authorized in Australia, Lithuania, Nigeria, New Zealand, Romania, South Africa

Active ingredients

The drug CIFRAN contains one active pharmaceutical ingredient (API):

1 Ciprofloxacin UNII 4BA73M5E37 - CIPROFLOXACIN HYDROCHLORIDE

Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination. Read about Ciprofloxacin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01MA02	Ciprofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1209P
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1004639
Country: NG	Registered Drug Product Database	Identifier(s): 04-2613, 04-4673
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 10755, 10756, 10757
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65056001, W65057001
Country: ZA	Health Products Regulatory Authority	Identifier(s): 33/20.1.1/0365, 33/20.1.1/0366